COX15

protein-coding

cytochrome c oxidase assembly homolog COX15, the group of Mitochondrial respiratory chain complex assembly factors

Gene summary

Cytochrome c oxidase (COX), the terminal component of the mitochondrial respiratory chain, catalyzes the electron transfer from reduced cytochrome c to oxygen. This component is a heteromeric complex consisting of 3 catalytic subunits encoded by mitochondrial genes and multiple structural subunits encoded by nuclear genes. The mitochondrially-encoded subunits function in electron transfer, and the nuclear-encoded subunits may function in the regulation and assembly of the complex. This nuclear gene encodes a protein which is not a structural subunit, but may be essential for the biogenesis of COX formation and may function in the hydroxylation of heme O, according to the yeast mutant studies. This protein is predicted to contain 5 transmembrane domains localized in the mitochondrial inner membrane. Alternative splicing of this gene generates two transcript variants diverging in the 3' region. [provided by RefSeq, Jul 2008]

MANE transcript

NM_078470.6

Inheritance

AR

ClinVar variants

P:50U:118B:126

Top phenotype

Mitochondrial complex IV deficiency, nuclear type 6

gnomAD constraint

pLI —, LoF o/e 0.92

Max pathogenic AF

—

Genomic locus

chr10:99,710,868-99,732,127

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~21.3 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

mitochondrial diseaseDEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0044970

Submitter: ClinGen

The relationship between *COX15* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of December 4, 2023. *COX15* encodes the cytochrome c oxidase assembly protein COX15 homolog protein, a transmembrane protein located at the mitochondrial inner membrane. *COX15* is a Complex IV assembly factor with is thought to be involved in the biosynthesis of heme A. Defects of this protein lead to complex IV deficiency. *COX15* was first reported in relation to autosomal recessive primary mitochondrial disease in 2003 in an individual with fatal, infantile hypertrophic cardiomyopathy (PMID: 12474143). While various names could be given to the constellation of features seen in those with *COX15*-related disease, pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the *COX15* phenotype has been lumped into one disease entity according to the ClinGen Lumping and Splitting Framework. Of note, *COX15* was previously curated by this GCEP on April 22, 2019 (SOP Version 6) as having a Limited association with Leigh Syndrome Spectrum (LSS). The scope of this current curation encompassed cases of primary mitochondrial disease, which includes LSS. Evidence supporting the gene-disease relationship between *COX15* and primary mitochondrial disease includes case-level data and experimental data. This curation includes six unique variants (four missense including the p.Arg217Trp variant that appears to be recurrent as it was scored in five probands from different populations, one nonsense, one splicing) in nine probands from nine publications (PMIDs: 15235026, 12474143, 15863660, 21412973, 26959537, 32232962, 33746038, 34440436, 31967322). Affected individuals present with a broad phenotypic spectrum of disease which may include seizures, hypotonia, ataxia, psychomotor retardation, vision loss, dysphagia, microcephaly, encephalopathy, and gliosis as well as cardiomyopathy. MRI findings are often consistent with LSS. The age of onset ranges from birth to early childhood. Where assessed, affected individuals present with persistent lactic acidosis and complex IV deficiency. Loss of function is implicated as the mechanism of disease. This gene-disease association is also supported by known biochemical function, functional alteration in patient fibroblasts, and a mouse model which recapitulates aspects of mitochondrial disease (PMIDs: 33340416, 12474143, 21723506, 26039449). In summary, there is definitive evidence to support this gene-disease relationship, including that more than three years have elapsed from the first proposal of the association. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on December 4, 2023 (SOP Version 9).

Leigh syndromeLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0009723

Submitter: ClinGen

The relationship between COX15 and Leigh syndrome spectrum was evaluated using the ClinGen Clinical Validity Framework as of April 22, 2019. 11 articles were reviewed. COX15 was first reported in relation to autosomal recessive Leigh syndrome spectrum in 2004 (Oquendo et al., PMID: 15235026). Five unique variants predicted to cause a loss of or reduced function of the protein have been reported in ClinVar. Complex IV deficiency is the mechanism of disease for this gene. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 1 proband with Leigh syndrome spectrum in 1 publication (PMID 15235026 ). This gene-disease association is further supported by the function of the gene product, expression, and studies in patient cell lines and a COX15 mouse model. In summary, there is limited evidence to support the relationship between COX15 and autosomal recessive Leigh syndrome spectrum. This classification was approved by the NICHD U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on April 22, 2019 (SOP Version 6).

cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2MODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0014051

Submitter: Ambry Genetics

cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0014051

Submitter: G2P

cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0014051

Submitter: Labcorp Genetics (formerly Invitae)

Clinical Genomic Database (CGD)

Mitochondrial complex IV deficiency, nuclear type 6AR

Manifestation: Biochemical; Cardiovascular; Musculoskeletal; Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 2175025; 12474143; 15235026; 15863660; 21412973Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to COX15 variants in ClinVar

8 Conditions Cataloged
not providedTotal: 347
not specifiedTotal: 53
Inborn genetic diseasesTotal: 45
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2Total: 31
Leigh syndromeTotal: 26
COX15-related disorderTotal: 11
CardiomyopathyTotal: 1
See casesTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_078470.6. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
4
clinvar
112
clinvar
1
clinvar
117
missense
1
clinvar
5
clinvar
109
clinvar
13
clinvar
128
nonsense
6
clinvar
9
clinvar
2
clinvar
17
start loss
0
frameshift
11
clinvar
4
clinvar
2
clinvar
17
splice donor/acceptor (+/-2bp)
14
clinvar
1
clinvar
15
Total18321181251294

Highest pathogenic variant AF is 0.0003302203

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 28 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_078470.6RefSeqNP_510870.19MANE Select
ENST00000016171.6EnsemblENSP00000016171.69MANE Select
NM_001320974.2RefSeqNP_001307903.19Standard
NM_001320975.2RefSeqNP_001307904.17Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Thermogenesis - Homo sapiens (human)
  • Oxidative phosphorylation - Homo sapiens (human)
  • Porphyrin and chlorophyll metabolism - Homo sapiens (human)
  • Hereditary Coproporphyria (HCP)
  • Porphyria Variegata (PV)

Biological Process

  • mitochondrial electron transport, cytochrome c to oxygen
  • heme biosynthetic process
  • heme a biosynthetic process
  • respiratory gaseous exchange
  • respiratory chain complex IV assembly

Molecular Function

  • cytochrome-c oxidase activity
  • protein binding
  • oxidoreductase activity, acting on the CH-CH group of donors
  • oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor

Cellular Component

  • nucleus
  • mitochondrion
  • mitochondrial inner membrane
  • mitochondrial respirasome
  • integral component of membrane

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000016171
Coding exons
9
Length
20257
Individuals with no LoFs
125617
Homozygous LoFs
0
Heterozygous LoFs
131
Defined
125748
p
0.000521
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.2622082190.9500.00001232603
Missense (PolyPhen)7280.5590.89375967
Synonymous-0.1778784.91.020.00000448870
Loss of Function0.3482122.80.9210.00000128253

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000310.00031rare
Latino/Admixed American0.000640.00064rare
Ashkenazi Jewish00.0absent
East Asian0.000330.00033rare
Finnish0.0000460.000046rare
European (Non-Finnish)0.000690.00069rare
South Asian0.000390.00039rare
Other0.00110.0011notable

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: May be involved in the biosynthesis of heme A. {ECO:0000269|PubMed:12474143}.;
Disease
DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset progressive neurodegenerative disorder characterized by the presence of focal, bilateral lesions in one or more areas of the central nervous system including the brainstem, thalamus, basal ganglia, cerebellum and spinal cord. Clinical features depend on which areas of the central nervous system are involved and include subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, and dysphagia. {ECO:0000269|PubMed:15235026, ECO:0000269|PubMed:15863660}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.147

Intolerance Scores

LoFtool
0.167
RVIS EVS
-0.25
RVIS percentile EVS
36.07

Essentials

Essential (CRISPR)
E
Essential (CRISPR2)
E
Essential (gene trap)
E
Indispensability pred.
E
Indispensability score
0.990

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.